SYNCOMF — Syncom Formulations (India) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual balance sheet for Syncom Formulations (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	784	477	745	1,356	935
Net Total Accounts Receivable
Net Total Receivables	748	676	833	1,140	1,130
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,898	1,398	1,817	2,748	2,700
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	446	527	688	723	775
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,916	3,082	3,778	4,047	4,133
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	967	783	1,132	1,062	593
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,041	860	1,218	1,165	711
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	1,876	2,222	2,560	2,881	3,422
Total Liabilities & Shareholders' Equity	2,916	3,082	3,778	4,047	4,133
Total Common Shares Outstanding